Weihai Baihe Biology Technological (SH:603102) Shang Hai Zheng Quan Bao·2025-10-29 23:39Core Viewpoint - The announcement provides an overview of the financial performance and operational data of Weihai Bihua Biotechnology Co., Ltd. for the third quarter of 2025, emphasizing the accuracy and completeness of the reported information [1][2][8]. Financial Data Summary - The financial statements for the third quarter of 2025 are unaudited, covering the period from the beginning to the end of the quarter [3][7]. - The company confirms that there are no significant changes in the financial indicators compared to previous periods, and the financial information is guaranteed to be true and complete by the management [2][5]. Operational Performance - The announcement includes key operational data categorized by product type, sales model, and regional distribution, although specific figures are not provided in the text [8]. - The company has reported changes in the number of distributors during the third quarter, indicating adjustments in its distribution network [8]. Management Assurance - The board of directors and senior management affirm their responsibility for the accuracy and completeness of the quarterly report, ensuring that there are no misleading statements or omissions [1][2].